{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:40:10Z","timestamp":1758973210964,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.annder.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T16:27:32Z","timestamp":1679502452000},"page":"160-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Severe inflammatory tinea capitis in a child receiving baricitinib therapy for alopecia areata"],"prefix":"10.1016","volume":"150","author":[{"given":"S.","family":"Rotaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3496-5842","authenticated-orcid":false,"given":"M.","family":"Common","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5780-1827","authenticated-orcid":false,"given":"E.","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2023.02.001_b0005","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/JIR.S356316","article-title":"Application of Baricitinib in Dermatology","volume":"15","author":"Zhang","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.annder.2023.02.001_b0010","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two Phase 3 Trials of Baricitinib for Alopecia Areata","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2023.02.001_b0015","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1093\/rheumatology\/keab658","article-title":"Cryptococcal pneumonia in a patient with rheumatoid arthritis treated with baricitinib","volume":"24","author":"Li","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2023.02.001_b0020","doi-asserted-by":"crossref","first-page":"e15351","DOI":"10.1111\/dth.15351","article-title":"Disseminated tinea corporis under baricitinib therapy for atopic dermatitis","volume":"35","author":"Fiocco","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2023.02.001_b0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/14397595.2019.1583711","article-title":"Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials","volume":"30","author":"Harigai","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.annder.2023.02.001_b0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/imj.14319","article-title":"Tofacitinib: raising awareness of mycoses","volume":"49","author":"Dyer","year":"2019","journal-title":"Intern Med J"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963823000121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963823000121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:11:25Z","timestamp":1758971485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963823000121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0151963823000121"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2023.02.001","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe inflammatory tinea capitis in a child receiving baricitinib therapy for alopecia areata","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}